Host: Susan Dolan, RN, JD

Guest: John Carney, MEd

Hear John Carney, Vice President, Aging and End of Life, at the Center for Practical Bioethics in Kansas City, MO as he discusses the futility laws and the Baby Emilio case.

Host: Susan Dolan, RN, JD

Guest: Jacob Teitelbaum, MD

Join Dr. Jacob Teitelbaum, Director of the Fibromyalgia & Fatigue Centers and author of "From Fatigued to Fantastic" discuss the latest research, and treatment of chronic fatigue.

Host: Susan Dolan, RN, JD

Guest: Jacob Teitelbaum, MD

Join Dr. Jacob Teitelbaum, Medical Director of the Fibromyalgia and Fatigue Centers and author of "From Fatigued to Fantastic" as he offers a Chronic Fatigue Syndrome 101.

Host: Lee Freedman, MD

Guest: Thomas Sequist, MD

Dr. Sequist discusses the details of his summer research program for Native Americans at Harvard Medical School called "Four Directions."

Host: Lee Freedman, MD

Guest: Thomas Sequist, MD

Dr. Sequist discusses current initiatves to improve healthcare provdied to Native Americans

Host: Lee Freedman, MD

Guest: Thomas Sequist, MD

Dr. Sequist discusses the inequities in care for Native Americans compared to other populations in the U.S.

Host: Lee Freedman, MD

Guest: Joshua Cohen, PhD

Dr. Cohen discusses how benefit must be taken into account when considering the overall effect of medications on our patients.

Host: Lee Freedman, MD

Guest: Joshua Cohen, PhD

Dr. Cohen discusses how comparison of drug risks to risks of more well recognized activities in the arenas of occupations, transportation and recreation can help patients put medication risk into perspective.

Host: Matthew J. Sorrentino, MD, FACC, FASH

Guest: Robert S. Rosenson, MD

Will novel HDL cholesterol therapies reduce cardiovascular risk? Dr. Robert Rosenson will discuss the hope for CETP inhibitors and HDL mimetics to modify HDL cholesterol and coronary heart disease risk.

Host: Matthew J. Sorrentino, MD, FACC, FASH

Guest: Robert S. Rosenson, MD

Dr. Robert Rosenson, Director of Lipoprotein Disorders at the University of Michigan, will review the importance of HDL cholesterol and how we can try to raise the HDL levels for cardiac protection.